| 摘要 |
The present disclosure is related to pharmaceutical compositions based on Alfaceto analogues derived from essential amino acids, an oligosaccharide and calcium citrate, useful for improving the general condition of patients with energy and protein loss. A process for manufacturing pharmaceutical compositions containing Alfaceto analogues derived from essential amino acids, an oligosaccharide and calcium citrate, useful for improving the general condition of patients with energy and proteins loss and the uses of the mentioned compositions to prevent and improve the treatment of patients with chronic renal failure in each one of the stages of chronic kidney disease CKD, with remaining renal response RRR, stages I, II, III, stage IV of the chronic renal failure CRF, Equivalent to the CRF without dialysis requirement, stage V of the chronic renal failure CRF, equivalent to a CRF in hemodialysis, Stage V of the chronic renal failure CRF, equivalent to CRF in peritoneal dialysis, or post-re nal transplantation. |
